Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials-Reference-Cited by-同舟云学术

Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors – An analysis of 2765 patients from neoadjuvant clinical trials

Published:2021-05 Issue: Volume:148 Page:159-170
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Villegas Sonia L.,Nekljudova Valentina^ORCID,Pfarr Nicole^ORCID,Engel Jutta,Untch Michael,Schrodi Simone,Holms Frank,Ulmer Hans U.,Fasching Peter A.,Weber Karsten E.,Albig Christian^ORCID,Heinrichs Clemens^ORCID,Marmé Frederik^ORCID,Hartmann Arndt,Hanusch Claus,Schmitt Wolfgang D.^ORCID,Huober Jens,Lederer Bianca^ORCID,van Mackelenbergh Marion,Tesch Hans,Jackisch Christian,Rezai Mahdi,Sinn Peter,Sinn Bruno V.,Hackmann John,Kiechle Marion,Schneeweiss Andreas,Weichert Wilko,Denkert Carsten,Loibl Sibylle^ORCID

Funder

German Cancer Aid

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

3. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Senkus;Ann Oncol,2015

4. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer;Hammond;Arch Pathol Lab Med,2010

5. Current status of estrogen receptors in human breast cancer;McGuire;Cancer,1975

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Major pathologic response and long-term clinical benefit in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after neoadjuvant chemotherapy;The Breast;2024-12

2. MRI features of breast cancer immunophenotypes with a focus on luminal estrogen receptor low positive invasive carcinomas;Scientific Reports;2024-08-20

3. Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer;JNCI: Journal of the National Cancer Institute;2024-07-31

4. Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer;Cancer Treatment Reviews;2024-07

5. A population-based study on trajectories of HER2 status during neoadjuvant chemotherapy for early breast cancer and metastatic progression;British Journal of Cancer;2024-06-28